Head & Neck Cancer | Tumor

CURE’s head & neck cancer page is a go-to resource for oncology news and updates in the world of head & neck cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight to the latest treatments and research in head & neck cancer.

A Stepped Approach to Psychosocial Care in Head and Neck Cancer Is Cost-Effective

December 21st 2016

A four-step approach proved to be beneficial in offering psychosocial support to patients with head and neck cancer.

His Final Law: 21st Century Cures Act Signed by President Obama

December 14th 2016

President Barack Obama signed the 21st Century Cures Act into law, allocating more than $6 billion for precision medicine, research, drug abuse prevention and mental health over the next decade.

The Importance of Survivorship Care for Head and Neck Cancer

December 13th 2016

Nurses at the Cleveland Clinic are pushing to make survivorship care the norm for survivors of head and neck cancer.

What's Next in Immunotherapy?

December 3rd 2016

Melanoma should not be considered to be in a "special category" that responds well to immunotherapy, according to Christian M. Capitini, M.D., assistant professor of Pediatrics at the University of Wisconsin.

Experts Discuss Immunotherapy's Role in the Shifting Landscape in Solid Tumors

November 30th 2016

A panel of experts recently discussed the evolving field of immunotherapy for solid tumor types.

New Combo Proves Highly Effective in Head and Neck Cancer

November 26th 2016

The combination of lirilumab Opdivo proved to be effective for a subet of patients with head and neck cancer, according to a recent study.

Examining the Future of Immunotherapy in Head and Neck Cancer

November 18th 2016

Everett Vokes, M.D. discusses what the future of immunotherapy might mean for patients with head and neck cancer.

Opdivo Approved in Head and Neck Cancer Subset

November 11th 2016

Opdivo was approved for patients with metastatic or recurrent squamous cell carcinoma of the head and neck.

A Perfect Pair: Expert Discusses the Future of Immunotherapy Combinations

November 2nd 2016

In an interview with CURE, James Allison, Ph.D. talks about the progress immunotherapy has made, as well as potential combinations with immunotherapy and other treatment types to provide better outcomes for patients.

Adding Immunotherapy to Standard Care Showed No Benefit for Head and Neck Cancer

October 13th 2016

The addition of immunotherapy did not show an improved progression-free survival for some patients with head and neck cancer.

Keytruda Just the Beginning for Immunotherapies in Head and Neck Cancer

September 30th 2016

The approval of Keytruda for metastatic head and neck squamous cell carcinoma is just the beginning when it comes to treating head and neck cancer with immunotherapy.

FDA Approves Keytruda for Head and Neck Cancer

August 6th 2016

An accelerated FDA approval has been granted to the immunotherapy Keytruda for patients with recurrent or metastatic head and neck squamous cell carcinoma following progression on a platinum-containing chemotherapy.

Gilotrif Trials Halted in Head and Neck Cancer Due to Lack of Efficacy

July 27th 2016

Two trials testing Gilotrif's efficacy in head and neck cancer were stopped after a panel decided it was unlikely the drug would prove beneficial.

Treatment Advances Lead to More Individualized Care for Elderly Patients With Head and Neck Cancer

July 15th 2016

Elderly patients with head and neck cancer will now be able to get more individualized treatment plans, thanks to advances in the field, Sandro V. Porceddu says.

Expert Reviews Potential of Keytruda in Head and Neck Cancer

July 1st 2016

The need for new treatment options for patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) is dire, says Ranee Mehra.

New Study Analyzes Physical Therapy for Head and Neck Cancer Survivors

June 22nd 2016

Survivors of head and neck cancer often face unique challenges, and physical therapy can help.

Keytruda Continues to Show Activity in Head and Neck Cancer

June 16th 2016

Keytruda is showing promise for difficult-to-treat forms of head and neck cancer, according to two studies.

Opdivo Improves Overall Survival, Objective Response Rate in Head and Neck Cancer

June 7th 2016

According to results from a phase 3 study, Opdivo improved overall survival and objective response rates for patients with recurrent or metastatic head and neck squamous cell carcinoma.

Examining the Promise of Immunotherapy in Head and Neck Cancer

June 1st 2016

Immunotherapy is showing promise for treatment of head and neck cancer who progress after chemotherapy, though there is still a long way to go, says Robert Ferris.

Patients With Head and Neck Cancer Benefit From Team-Based Approach to Care

April 29th 2016

A team approach to treatment could improve outcomes for patients with head and neck cancer.

Finding Cancer Comfort in a Four-Legged Friend

April 29th 2016

Being covered in cat fur feels wonderful.

Momentum Continues for Opdivo in Head and Neck Cancer

April 25th 2016

The FDA granted Opdivo (nivolumab) a breakthrough therapy designation to treat certain patients with head and neck cancer.

Opdivo Doubles One-Year Survival Rate in Head and Neck Cancer

April 22nd 2016

A phase 3 study presented at the 2016 AACR Annual Meeting showed that Opdivo doubled one-year survival rate for patients with recurrent or metastatic head and neck squamous cell carcinoma.

With Cancer, Waiting Is the Hardest Part

April 14th 2016

Keytruda Nears Approval for Head and Neck Cancer

April 14th 2016

A priority review designation was granted to Keytruda for some patients with head and neck cancer. A decision submission is due in August.

Five Key Areas Defined in New Guidelines for Head and Neck Cancer Survivorship Care

April 1st 2016

As the number of HNC survivors continues to increase, the American Cancer Society issued new guidelines for patients and their physicians.

Get a Grip: When Cancer Brings Irrational Fears

March 29th 2016

Sometimes rational thinking isn't my strong suit.

Providing a Dedicated Network of Support for People with HNC

March 22nd 2016

The News Is Bleak and Then It Gets Worse

February 24th 2016

For more than a year, the pain and restricted movement in my jaw are diagnosed as a common joint disorder, but a loss of hearing changes everything.

Pass the Ice Cream: Dealing With Bad Days as a Cancer Survivor

February 11th 2016

Like the song goes: "Some days are diamonds, some days are stones."